This report contains market size and forecasts of Biosimilars in global, including the following market information:
Global Biosimilars Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Biosimilars Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Biosimilars companies in 2020 (%)
The global Biosimilars market was valued at 5893.3 million in 2020 and is projected to reach US$ 11130 million by 2027, at a CAGR of 17.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Biosimilars Market Segment Percentages, By Type, 2020 (%)
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Recombinant Glycosylated Proteins
Global Biosimilars Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Biosimilars Market Segment Percentages, By Application, 2020 (%)
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Global Biosimilars Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Biosimilars Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Biosimilars revenues share in global market, 2020 (%)
Key companies Biosimilars sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Biosimilars sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Biocon
Biogen
Fresenius Kabi AG
Boehringer Ingelheim
Merck KgaA
Mylan
Eli Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Amgen
Celltrion
Samsung Biologics
Roche
Probiomed
Apotex
Chong Kun Dang
JCR Pharmaceuticals
Gan & Lee Pharmaceuticals
Gedeon Richter
Biocad
Coherus Bioscience
Stada Arzneimittel AG
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars Overall Market Size
2.1 Global Biosimilars Market Size: 2021 VS 2027
2.2 Global Biosimilars Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Biosimilars Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Biosimilars Players in Global Market
3.2 Top Global Biosimilars Companies Ranked by Revenue
3.3 Global Biosimilars Revenue by Companies
3.4 Global Biosimilars Sales by Companies
3.5 Global Biosimilars Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Biosimilars Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilars Market Size Markets, 2021 & 2027
4.1.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
4.1.3 Recombinant Glycosylated Proteins
4.2 By Type - Global Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biosimilars Revenue, 2016-2021
4.2.2 By Type - Global Biosimilars Revenue, 2022-2027
4.2.3 By Type - Global Biosimilars Revenue Market Share, 2016-2027
4.3 By Type - Global Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biosimilars Sales, 2016-2021
4.3.2 By Type - Global Biosimilars Sales, 2022-2027
4.3.3 By Type - Global Biosimilars Sales Market Share, 2016-2027
4.4 By Type - Global Biosimilars Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilars Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Blood Disorders
5.1.4 Growth Hormonal Deficiency
5.1.5 Chronic and Autoimmune Disorders
5.1.6 Others
5.2 By Application - Global Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biosimilars Revenue, 2016-2021
5.2.2 By Application - Global Biosimilars Revenue, 2022-2027
5.2.3 By Application - Global Biosimilars Revenue Market Share, 2016-2027
5.3 By Application - Global Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biosimilars Sales, 2016-2021
5.3.2 By Application - Global Biosimilars Sales, 2022-2027
5.3.3 By Application - Global Biosimilars Sales Market Share, 2016-2027
5.4 By Application - Global Biosimilars Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Biosimilars Market Size, 2021 & 2027
6.2 By Region - Global Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biosimilars Revenue, 2016-2021
6.2.2 By Region - Global Biosimilars Revenue, 2022-2027
6.2.3 By Region - Global Biosimilars Revenue Market Share, 2016-2027
6.3 By Region - Global Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biosimilars Sales, 2016-2021
6.3.2 By Region - Global Biosimilars Sales, 2022-2027
6.3.3 By Region - Global Biosimilars Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Biosimilars Revenue, 2016-2027
6.4.2 By Country - North America Biosimilars Sales, 2016-2027
6.4.3 US Biosimilars Market Size, 2016-2027
6.4.4 Canada Biosimilars Market Size, 2016-2027
6.4.5 Mexico Biosimilars Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Biosimilars Revenue, 2016-2027
6.5.2 By Country - Europe Biosimilars Sales, 2016-2027
6.5.3 Germany Biosimilars Market Size, 2016-2027
6.5.4 France Biosimilars Market Size, 2016-2027
6.5.5 U.K. Biosimilars Market Size, 2016-2027
6.5.6 Italy Biosimilars Market Size, 2016-2027
6.5.7 Russia Biosimilars Market Size, 2016-2027
6.5.8 Nordic Countries Biosimilars Market Size, 2016-2027
6.5.9 Benelux Biosimilars Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Biosimilars Revenue, 2016-2027
6.6.2 By Region - Asia Biosimilars Sales, 2016-2027
6.6.3 China Biosimilars Market Size, 2016-2027
6.6.4 Japan Biosimilars Market Size, 2016-2027
6.6.5 South Korea Biosimilars Market Size, 2016-2027
6.6.6 Southeast Asia Biosimilars Market Size, 2016-2027
6.6.7 India Biosimilars Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Biosimilars Revenue, 2016-2027
6.7.2 By Country - South America Biosimilars Sales, 2016-2027
6.7.3 Brazil Biosimilars Market Size, 2016-2027
6.7.4 Argentina Biosimilars Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilars Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Biosimilars Sales, 2016-2027
6.8.3 Turkey Biosimilars Market Size, 2016-2027
6.8.4 Israel Biosimilars Market Size, 2016-2027
6.8.5 Saudi Arabia Biosimilars Market Size, 2016-2027
6.8.6 UAE Biosimilars Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Biosimilars Major Product Offerings
7.1.4 Pfizer Biosimilars Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Biosimilars Major Product Offerings
7.2.4 Novartis Biosimilars Sales and Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Biocon
7.3.1 Biocon Corporate Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Biosimilars Major Product Offerings
7.3.4 Biocon Biosimilars Sales and Revenue in Global (2016-2021)
7.3.5 Biocon Key News
7.4 Biogen
7.4.1 Biogen Corporate Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Biosimilars Major Product Offerings
7.4.4 Biogen Biosimilars Sales and Revenue in Global (2016-2021)
7.4.5 Biogen Key News
7.5 Fresenius Kabi AG
7.5.1 Fresenius Kabi AG Corporate Summary
7.5.2 Fresenius Kabi AG Business Overview
7.5.3 Fresenius Kabi AG Biosimilars Major Product Offerings
7.5.4 Fresenius Kabi AG Biosimilars Sales and Revenue in Global (2016-2021)
7.5.5 Fresenius Kabi AG Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Biosimilars Major Product Offerings
7.6.4 Boehringer Ingelheim Biosimilars Sales and Revenue in Global (2016-2021)
7.6.5 Boehringer Ingelheim Key News
7.7 Merck KgaA
7.7.1 Merck KgaA Corporate Summary
7.7.2 Merck KgaA Business Overview
7.7.3 Merck KgaA Biosimilars Major Product Offerings
7.4.4 Merck KgaA Biosimilars Sales and Revenue in Global (2016-2021)
7.7.5 Merck KgaA Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Biosimilars Major Product Offerings
7.8.4 Mylan Biosimilars Sales and Revenue in Global (2016-2021)
7.8.5 Mylan Key News
7.9 Eli Lilly
7.9.1 Eli Lilly Corporate Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biosimilars Major Product Offerings
7.9.4 Eli Lilly Biosimilars Sales and Revenue in Global (2016-2021)
7.9.5 Eli Lilly Key News
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Corporate Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Biosimilars Major Product Offerings
7.10.4 Teva Pharmaceutical Biosimilars Sales and Revenue in Global (2016-2021)
7.10.5 Teva Pharmaceutical Key News
7.11 Dr. Reddy's Laboratories
7.11.1 Dr. Reddy's Laboratories Corporate Summary
7.11.2 Dr. Reddy's Laboratories Biosimilars Business Overview
7.11.3 Dr. Reddy's Laboratories Biosimilars Major Product Offerings
7.11.4 Dr. Reddy's Laboratories Biosimilars Sales and Revenue in Global (2016-2021)
7.11.5 Dr. Reddy's Laboratories Key News
7.12 Amgen
7.12.1 Amgen Corporate Summary
7.12.2 Amgen Biosimilars Business Overview
7.12.3 Amgen Biosimilars Major Product Offerings
7.12.4 Amgen Biosimilars Sales and Revenue in Global (2016-2021)
7.12.5 Amgen Key News
7.13 Celltrion
7.13.1 Celltrion Corporate Summary
7.13.2 Celltrion Biosimilars Business Overview
7.13.3 Celltrion Biosimilars Major Product Offerings
7.13.4 Celltrion Biosimilars Sales and Revenue in Global (2016-2021)
7.13.5 Celltrion Key News
7.14 Samsung Biologics
7.14.1 Samsung Biologics Corporate Summary
7.14.2 Samsung Biologics Business Overview
7.14.3 Samsung Biologics Biosimilars Major Product Offerings
7.14.4 Samsung Biologics Biosimilars Sales and Revenue in Global (2016-2021)
7.14.5 Samsung Biologics Key News
7.15 Roche
7.15.1 Roche Corporate Summary
7.15.2 Roche Business Overview
7.15.3 Roche Biosimilars Major Product Offerings
7.15.4 Roche Biosimilars Sales and Revenue in Global (2016-2021)
7.15.5 Roche Key News
7.16 Probiomed
7.16.1 Probiomed Corporate Summary
7.16.2 Probiomed Business Overview
7.16.3 Probiomed Biosimilars Major Product Offerings
7.16.4 Probiomed Biosimilars Sales and Revenue in Global (2016-2021)
7.16.5 Probiomed Key News
7.17 Apotex
7.17.1 Apotex Corporate Summary
7.17.2 Apotex Business Overview
7.17.3 Apotex Biosimilars Major Product Offerings
7.17.4 Apotex Biosimilars Sales and Revenue in Global (2016-2021)
7.17.5 Apotex Key News
7.18 Chong Kun Dang
7.18.1 Chong Kun Dang Corporate Summary
7.18.2 Chong Kun Dang Business Overview
7.18.3 Chong Kun Dang Biosimilars Major Product Offerings
7.18.4 Chong Kun Dang Biosimilars Sales and Revenue in Global (2016-2021)
7.18.5 Chong Kun Dang Key News
7.19 JCR Pharmaceuticals
7.19.1 JCR Pharmaceuticals Corporate Summary
7.19.2 JCR Pharmaceuticals Business Overview
7.19.3 JCR Pharmaceuticals Biosimilars Major Product Offerings
7.19.4 JCR Pharmaceuticals Biosimilars Sales and Revenue in Global (2016-2021)
7.19.5 JCR Pharmaceuticals Key News
7.20 Gan & Lee Pharmaceuticals
7.20.1 Gan & Lee Pharmaceuticals Corporate Summary
7.20.2 Gan & Lee Pharmaceuticals Business Overview
7.20.3 Gan & Lee Pharmaceuticals Biosimilars Major Product Offerings
7.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales and Revenue in Global (2016-2021)
7.20.5 Gan & Lee Pharmaceuticals Key News
7.21 Gedeon Richter
7.21.1 Gedeon Richter Corporate Summary
7.21.2 Gedeon Richter Business Overview
7.21.3 Gedeon Richter Biosimilars Major Product Offerings
7.21.4 Gedeon Richter Biosimilars Sales and Revenue in Global (2016-2021)
7.21.5 Gedeon Richter Key News
7.22 Biocad
7.22.1 Biocad Corporate Summary
7.22.2 Biocad Business Overview
7.22.3 Biocad Biosimilars Major Product Offerings
7.22.4 Biocad Biosimilars Sales and Revenue in Global (2016-2021)
7.22.5 Biocad Key News
7.23 Coherus Bioscience
7.23.1 Coherus Bioscience Corporate Summary
7.23.2 Coherus Bioscience Business Overview
7.23.3 Coherus Bioscience Biosimilars Major Product Offerings
7.23.4 Coherus Bioscience Biosimilars Sales and Revenue in Global (2016-2021)
7.23.5 Coherus Bioscience Key News
7.24 Stada Arzneimittel AG
7.24.1 Stada Arzneimittel AG Corporate Summary
7.24.2 Stada Arzneimittel AG Business Overview
7.24.3 Stada Arzneimittel AG Biosimilars Major Product Offerings
7.24.4 Stada Arzneimittel AG Biosimilars Sales and Revenue in Global (2016-2021)
7.24.5 Stada Arzneimittel AG Key News
8 Global Biosimilars Production Capacity, Analysis
8.1 Global Biosimilars Production Capacity, 2016-2027
8.2 Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilars Supply Chain Analysis
10.1 Biosimilars Industry Value Chain
10.2 Biosimilars Upstream Market
10.3 Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Biosimilars in Global Market
Table 2. Top Biosimilars Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Biosimilars Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Biosimilars Revenue Share by Companies, 2016-2021
Table 5. Global Biosimilars Sales by Companies, (K MT), 2016-2021
Table 6. Global Biosimilars Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Biosimilars Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Biosimilars Product Type
Table 9. List of Global Tier 1 Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Pfizer
Novartis
Biocon
Biogen
Fresenius Kabi AG
Boehringer Ingelheim
Merck KgaA
Mylan
Eli Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Amgen
Celltrion
Samsung Biologics
Roche
Probiomed
Apotex
Chong Kun Dang
JCR Pharmaceuticals
Gan & Lee Pharmaceuticals
Gedeon Richter
Biocad
Coherus Bioscience
Stada Arzneimittel AG
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)